Johnson & Johnson vs Viatris Inc.
JNJ vs VTRS — side-by-side comparison from reported financials. JNJ leads 7, VTRS leads 4 of 11 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Viatris Inc.
VTRS · Healthcare
$17.64+1.15%Mixed
| Metric | JNJ | VTRS |
|---|---|---|
| Price | $261.79 | $17.64 |
| Market cap | $631B | $20.3B |
| Revenue (TTM) | $97.9B | $14.7B |
| Revenue growth | +5.6% | -4.2% |
| Net margin | 21.5% | -2.8% |
| Free cash flow | $22.2B | $1.95B |
| Net cash (debt) | ($27.8B) | ($11.2B) |
| 1-year price return | +37.0% | +76.6% |
| P/E | 29.9 | 5.5 |
| P/E vs own history (cheap-side %) | 16% | 9% |
| Dividend yield | 2.00% | 2.75% |
| Return on equity | 26% | -3% |
| Altman Z-score | — | 0.99 |
| CV checks passed | 10 of 11 | 6 of 11 |
| Employees | 140,800 | 30,000 |
Full résumé-style profiles: JNJ CV · VTRS CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.